Literature DB >> 2922288

AP-1/jun binding sites mediate serum inducibility of the human vimentin promoter.

S R Rittling1, L Coutinho, T Amram, M Kolbe.   

Abstract

The vimentin gene is inducible by serum in quiescent Balb/c 3T3 cells, but the molecular mechanism of this induction is unknown. The results presented here represent a first step towards the elucidation of the pathway of events leading from growth factor-receptor interaction to this induction. A series of Bal 31 deletions of the human vimentin promoter are used to show that a sequence residing at -700 is responsible for the serum, and also TPA inducibility of this gene. This sequence is able to confer serum inducibility upon uninducible constructs regardless of its position and orientation, indicating that it is this element alone which is required for this induction. The isolated sequence is a strong enhancer as well. Further deletions and the use of synthetic oligonucleotides demonstrate that a 24-mer containing two AP-1/jun binding sites confer both serum and TPA inducibility upon the human vimentin gene. Gel retardation analysis confirms that this sequence binds an AP-1 -like protein.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2922288      PMCID: PMC336896          DOI: 10.1093/nar/17.4.1619

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  41 in total

1.  Effect of protein synthesis inhibitors on growth factor activation of c-fos, c-myc, and actin gene transcription.

Authors:  M E Greenberg; A L Hermanowski; E B Ziff
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

2.  Expression of cell cycle-dependent genes in young and senescent WI-38 fibroblasts.

Authors:  S R Rittling; K M Brooks; V J Cristofalo; R Baserga
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

3.  Cell cycle dependent genes inducible by different mitogens in cells from different species.

Authors:  C W Gibson; S R Rittling; R R Hirschhorn; L Kaczmarek; B Calabretta; C D Stiles; R Baserga
Journal:  Mol Cell Biochem       Date:  1986-06       Impact factor: 3.396

4.  Identification of a transcriptional enhancer element upstream from the proto-oncogene fos.

Authors:  J Deschamps; F Meijlink; I M Verma
Journal:  Science       Date:  1985-12-06       Impact factor: 47.728

5.  Purification and biochemical characterization of the promoter-specific transcription factor, Sp1.

Authors:  M R Briggs; J T Kadonaga; S P Bell; R Tjian
Journal:  Science       Date:  1986-10-03       Impact factor: 47.728

6.  Induction of c-fos gene and protein by growth factors precedes activation of c-myc.

Authors:  R Müller; R Bravo; J Burckhardt; T Curran
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

7.  The effect of cycloheximide on the expression of cell cycle dependent genes.

Authors:  S R Rittling; C W Gibson; S Ferrari; R Baserga
Journal:  Biochem Biophys Res Commun       Date:  1985-10-15       Impact factor: 3.575

8.  Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors.

Authors:  R Treisman
Journal:  Cell       Date:  1986-08-15       Impact factor: 41.582

9.  Induction of cytoskeletal vimentin and actin gene expression by a tumor-promoting phorbol ester in the human leukemic cell line K562.

Authors:  P D Siebert; M Fukuda
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

10.  Induction of vimentin synthesis in mouse myeloma cells MPC-11 by 12-0-tetradecanoylphorbol-13-acetate.

Authors:  G Giese; P Traub
Journal:  Eur J Cell Biol       Date:  1986-04       Impact factor: 4.492

View more
  24 in total

Review 1.  Vimentin in cancer and its potential as a molecular target for cancer therapy.

Authors:  Arun Satelli; Shulin Li
Journal:  Cell Mol Life Sci       Date:  2011-06-03       Impact factor: 9.261

2.  Promoter-independent regulation of vimentin expression in mammary epithelial cells by val(12)ras and TGFbeta.

Authors:  Bradley Yates; Craig Zetterberg; Vaishali Rajeev; Michael Reiss; Susan R Rittling
Journal:  Exp Cell Res       Date:  2007-08-01       Impact factor: 3.905

3.  Effect of human T-cell leukemia virus type I tax protein on activation of the human vimentin gene.

Authors:  A Lilienbaum; M Duc Dodon; C Alexandre; L Gazzolo; D Paulin
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

4.  TGFbeta1 regulation of vimentin gene expression during differentiation of the C2C12 skeletal myogenic cell line requires Smads, AP-1 and Sp1 family members.

Authors:  Yongzhong Wu; Xueping Zhang; Morgan Salmon; Xia Lin; Zendra E Zehner
Journal:  Biochim Biophys Acta       Date:  2006-12-06

5.  Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.

Authors:  R M Tuder; B Groves; D B Badesch; N F Voelkel
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

6.  Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos.

Authors:  B Hengerer; D Lindholm; R Heumann; U Rüther; E F Wagner; H Thoenen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

7.  miR-375 Regulates Invasion-Related Proteins Vimentin and L-Plastin.

Authors:  Lizandra Jimenez; Jihyeon Lim; Berta Burd; Thomas M Harris; Thomas J Ow; Nicole Kawachi; Thomas J Belbin; Ruth Angeletti; Michael B Prystowsky; Geoffrey Childs; Jeffrey E Segall
Journal:  Am J Pathol       Date:  2017-05-10       Impact factor: 4.307

8.  Functional relevance of D,L-sulforaphane-mediated induction of vimentin and plasminogen activator inhibitor-1 in human prostate cancer cells.

Authors:  Avani R Vyas; Shivendra V Singh
Journal:  Eur J Nutr       Date:  2013-10-04       Impact factor: 5.614

9.  ZBP-89 represses vimentin gene transcription by interacting with the transcriptional activator, Sp1.

Authors:  Xueping Zhang; Iman H Diab; Zendra E Zehner
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

10.  Regulation of the mouse desmin gene: transactivated by MyoD, myogenin, MRF4 and Myf5.

Authors:  H Li; Y Capetanaki
Journal:  Nucleic Acids Res       Date:  1993-01-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.